Zusammenfassung
Hintergrund
Der „golden standard“ der Behandlung von Stenosen der A. carotis interna (ACI) ist die Karotisthrombendarteriektomie (CEA). Nach der aktuellen Leitlinie ist das Karotisstenting (CAS) eine Alternative. In mehreren prospektiven randomisierten Multi-Center-Studien zeigte CAS gegenüber CEA jedoch eine signifikant erhöhte periinterventionelle Schlaganfallrate. Diese Studien sind jedoch meist von einer großen Heterogenität bei der Durchführung von CAS gekennzeichnet.
Material und Methoden
In einer retrospektiven Analyse von 2012 bis 2020 wurden 202 symptomatische und symptomfreie Patienten mittels CAS therapiert. Es erfolgte eine sorgfältige Vorselektionierung der Patienten nach anatomischen und klinischen Kriterien. In allen Fällen wurden die gleiche Vorgehensweise und das gleiche Material gewählt. Alle Interventionen wurden ausschließlich durch 5 erfahrene Operateure durchgeführt. Ausgewertet wurden die anatomischen und klinischen Kriterien im Hinblick auf die perioperative Komplikationsrate. Primäre Endpunkte waren perioperativer Tod und Apoplex.
Ergebnisse
Bei 77 % der Patienten lag eine symptomfreie, bei 23 % eine symptomatische Karotisstenose vor. Das Durchschnittsalter war 66 Jahre. Der durchschnittliche Stenosegrad betrug 81 %. Die technische Erfolgsrate der CAS war 100 %. Unerwünschte periprozedurale Komplikationen traten in 1,5 % auf. Im Rahmen der Intervention ereigneten sich 1 „major stroke“ (0,5 %) und 2 „minor strokes“ (1 %).
Schlussfolgerungen
Die Ergebnisse dieser Studie weisen darauf hin, dass nach vorhergehender Patientenselektion anhand anatomischer und klinischer Kriterien CAS mit geringen Komplikationsraten durchgeführt werden kann. Eine Standarisierung von Materialien und Prozedur, konzentriert auf erfahrene Operateure mit entsprechendem Training sind entscheidend.
Graphic abstract
Abstract
Background
The gold standard for the treatment of internal carotid artery (ACI) stenosis is carotid thrombendarterectomy (CEA); however, according to the current guidelines, carotid artery stenting (CAS) is an alternative. In several prospective multicenter randomized studies, CAS showed a significantly increased peri-interventional stroke rate compared to CEA; however, these studies are usually characterized by a great heterogeneity in the procedure of CAS.
Material and methods
In a retrospective analysis from 2012 to 2020, 202 symptomatic and asymptomatic patients were treated with CAS. Patients were carefully preselected according to anatomical and clinical criteria. In all cases the same steps and material was used. All interventions were performed exclusively by five experienced surgeons. The anatomical and clinical criteria were evaluated with respect to the perioperative complication rate. The primary endpoints of the study were perioperative death and stroke.
Results
Asymptomatic carotid stenosis was present in 77% of the patients and symptomatic in 23%. The mean age was 66 years. The average degree of stenosis was 81%. The technical success rate of CAS was 100%. Adverse periprocedural complications occurred in 1.5%. During the intervention one major stroke (0.5%) and two minor strokes (1%) occurred.
Conclusion
The results of this study indicate that through a strict patient selection based on anatomical and clinical criteria, CAS can be performed with low complication rates. A standardization of materials and procedures, focused on experienced surgeons with appropriate training, is crucial.
Literatur
Statistisches Bundesamt Todesursachen in Deutschland 2015. Fachserie 12 Reihe 4 2017. https://www.destatis.de/GPStatistik/servlets/MCRFileNodeServlet/DEHeft_derivate_00030839/2120400157004_korr10032017.pdf. Zugegriffen: 22. Jan. 2022
Poeck K, Hacke W (2006) Zerebrale Durchblutungsstörungen: ischämische Infarkte. In: Poeck K, Hacke W (Hrsg) Neurologie. Springer, Heidelberg, S 164–222
Eckstein HH, Kühnl A, Berkefeld J et al S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der extracraniellen Carotisstenose. 2020; 2. Auflage. AWMF-Registern Nr. 004/028. https://www.awmf.org/uploads/tx_szleitlinien/004-028l_extracranielle-Carotisstenose-Diagnostik-Therapie-Nachsorge_2020-02_03.pdf. Zugegriffen: 22. Jan. 2021
Brott TG, Hobson RW 2nd, Howard G et al (2010) Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 363(1):11–23. https://doi.org/10.1056/NEJMoa0912321
SPACE Collaborative Group, Ringleb PA, Allenberg J, Brückmann H et al (2006) 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 368(9543):1239–1247. https://doi.org/10.1016/S0140-6736(06)69122-8
Mas JL, Chatellier G, Beyssen B et al (2006) Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355(16):1660–1671. https://doi.org/10.1056/NEJMoa061752
International Carotid Stenting Study investigators (2010) Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (international carotid stenting study): an interim analysis of a randomised controlled trial. Lancet 375(9719):985–997. https://doi.org/10.1016/S0140-6736(10)60239-5
Setacci C, Chisci E, Donato G de, ( et al (2007) Carotid artery stenting in a single center: are six years of experience enough to achieve the standard of care? Eur J Vasc Endovasc Surg 34(6):655–662. https://doi.org/10.1016/j.ejvs.2007.07.008
Werner M, Bausback Y, Bräunlich S et al (2012) Anatomic variables contributing to a higher periprocedural incidence of stroke and TIA in carotid artery stenting. Catheter Cardiovasc Interv 80(2):321–328. https://doi.org/10.1002/ccd.23483
Mayoral Campos V, Guirola Órtiz JA et al (2018) Carotid artery stenting in a single center, single operator, single type of device and 15 years of follow-up. Cvir Endovasc 1(1):3. https://doi.org/10.1186/s42155-018-0008-2
Reith W, Roth C (2010) CT-Diagnostik bei Karotisstenose. Radiologe 50:607–613. https://doi.org/10.1007/s00117-009-1933-9
Yadav JS, Wholey MH, Kuntz RE et al (2004) Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351(15):1493–1501. https://doi.org/10.1056/NEJMoa040127
Cavatas investigators (2001) Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS)
Rosenfield K, Matsumura JS, Chaturvedi S et al (2016) Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 374(9270):1011–1020. https://doi.org/10.1056/NEJMoa1515706
Halliday A, Bulbulia R, Bonati LH, et al & ACST‑2 Collaborative Group (2021) Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet 398(10305):1065–1073. https://doi.org/10.1016/S0140-6736(21)01910-3
International Carotid Stenting Study investigators, Bonati LH, Dobson J, Featherstone RL et al (2015) Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet 385(9967):529–538. https://doi.org/10.1016/S0140-6736(14)61184-3
Matsumura JS, Hanlon BM, Rosenfield K et al (2022) Treatment of carotid stenosis in asymptomatic, nonoctogenarian, standard risk patients with stenting versus endarterectomy trials. J Vasc Surg 75(4):1276–1283.e1. https://doi.org/10.1016/j.jvs.2021.10.020
Mukherjee D, Roffi M, Kapadia SR et al (2001) Percutaneous intervention for symptomatic vertebral artery stenosis using coronary stents. J Invasive Cardiol 13(5):363–366
Lin SC, Trocciola SM, Rhee J et al (2005) Analysis of anatomic factors and age in patients undergoing carotid angioplasty and stenting. Ann Vasc Surg 19(6):798–804. https://doi.org/10.1007/s10016-005-8045-4
Hicks CW, Malas MB (2019) Cerebrovascular disease-carotid artery stenting. In: Sidaway AN, Pearlier BA (Hrsg) Rutherford’s vascular surgery and endovascular therapy. Elsevier, Philadelphia, S 4071–4156
Suh GY, Beygui RE, Fleischmann D, Cheng CP (2014) Aortic arch vessel geometries and deformations in patients with thoracic aortic aneurysms and dissections. J Vasc Interv Radiol 25(12):1903–1911. https://doi.org/10.1016/j.jvir.2014.06.012
Doig D, Hobson BM, Müller M et al (2016) Carotid anatomy does not predict the risk of new Ischaemic brain lesions on diffusion-weighted imaging after carotid artery stenting in the ICSS-MRI Substudy. Eur J Vasc Endovasc Surg 51(1):14–20. https://doi.org/10.1016/j.ejvs.2015.08.012
Macdonald S, Lee R, Williams R et al (2009) Towards safer carotid artery stenting: a scoring system for anatomic suitability. Stroke 40(5):1698–1703. https://doi.org/10.1161/STROKEAHA.109.547117
Naggara O, Touzé E, Beyssen B et al (2011) Anatomical and technical factors associated with stroke or death during carotid angioplasty and stenting: results from the endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial and systematic review. Stroke 42(2):380–388. https://doi.org/10.1161/STROKEAHA.110.588772
de Weert TT, Ouhlous M, Meijering E et al (2006) In vivo characterization and quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation. Arterioscler Thromb Vasc Biol 26:2366–2372. https://doi.org/10.1161/01.ATV.0000240518.90124.57
Mathiesen EB, Joakimsen O, Bønaa KH (2001) Prevalence of and risk factors associated with carotid artery stenosis: the Tromsø Study. Cerebrovasc Dis 12(1):44–51. https://doi.org/10.1159/000047680
Naylor AR, Ricco JB, de Borst GJ et al (2018) Management of atherosclerotic carotid and vertebral artery disease: clinical practice guidelines of the european society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 55:3–81. https://doi.org/10.1016/j.ejvs.2017.06.021
Calvet D, Mas JL, Algra A et al (2014) Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists’ collaboration. Stroke 45(2):527–532. https://doi.org/10.1161/STROKEAHA.113.003526
Setacci C, Cremonesi A (2007) SPACE and EVA-3S trials: the need of standards for carotid stenting. Eur J Vasc Endovasc Surg 33(1):48–49. https://doi.org/10.1016/j.ejvs.2006.11.003
Hobson RW 2nd, Howard VJ, Roubin GS et al (2004) Credentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. J Vasc Surg 40(5):952–957. https://doi.org/10.1016/j.jvs.2004.08.039
Setacci C, Chisci E, Setacci F et al (2010) Siena carotid artery stenting score: a risk modelling study for individual patients. Stroke 41(6):1259–1265. https://doi.org/10.1161/STROKEAHA.110.578583
Bosiers M, de Donato G, Deloose K et al (2007) Does free cell area influence the outcome in carotid artery stenting? Eur J Vasc Endovasc Surg 33(2):135–141. https://doi.org/10.1016/j.ejvs.2006.09.019 (discussion 142–3)
Doig D, Turner EL, Dobson J et al (2016) Predictors of stroke, myocardial infarction or death within 30 days of carotid artery stenting: results from the international carotid stenting study. Eur J Vasc Endovasc Surg 51(3):327–334. https://doi.org/10.1016/j.ejvs.2015.08.013
Jansen O, Fiehler J, Hartmann M, Brückmann H (2009) Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial. Stroke 40(3):841–846. https://doi.org/10.1161/STROKEAHA.108.534289
Timaran CH, Rosero EB, Higuera A et al (2011) Randomized clinical trial of open-cell vs closed-cell stents for carotid stenting and effects of stent design on cerebral embolization. J Vasc Surg 54(5):1310–1316.e1. https://doi.org/10.1016/j.jvs.2011.05.013 (discussion 1316)
Jim J, Rubin BG, Landis GS et al (2011) Society for vascular surgery vascular registry evaluation of stent cell design on carotid artery stenting outcomes. J Vasc Surg 54(1):71–79. https://doi.org/10.1016/j.jvs.2010.12.054
Touzé E, Trinquart L, Chatellier G, Mas JL (2009) Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting. Stroke 40(12):e683–e693. https://doi.org/10.1161/STROKEAHA.109.562041
Bonati LH, Ederle J, McCabe DJ et al (2009) Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol 8(10):908–917. https://doi.org/10.1016/S1474-4422(09)70227-3
Fiehler J, Jansen O, Berger J et al (2008) Differences in complication rates among the centres in the SPACE study. Neuroradiology 50(12):1049–1053. https://doi.org/10.1007/s00234-008-0459-6
Institut für Qualitätssicherung und Transparenz im Gesundheitswesen (IQTIG) (2020) Karotis – Revaskularisation. https://iqtig.org/downloads/auswertung/2020/10n2karot/QSKH_10n2-KAROT_2020_BUAW_V01_2021-08-10.pdf. Zugegriffen: 23. Jan. 2021
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Calo und H. Görtz geben an, Honorare für Vorträge von der Firma Boston Scientific zu bekommen. A. Oberhuber gibt an, dass kein Interessenkonflikt besteht.
Alle beschriebenen retrospektive Untersuchungen am Menschen wurden mit Zustimmung der Ethik-Kommission der Ärztekammer Westfalen-Lippe und der Westfälischen Wilhelms-Universität Münster, im Einklang mit nationalem Recht sowie gemäß der Deklaration von Helsinki von 1975 (in der aktuellen, überarbeiteten Fassung) durchgeführt. Von allen beteiligten Patient/-innen liegt eine Einverständniserklärung vor.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Calo, P., Oberhuber, A. & Görtz, H. Kriterien für ein komplikationsarmes Stenting der A. carotis interna. Gefässchirurgie 27, 509–516 (2022). https://doi.org/10.1007/s00772-022-00940-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-022-00940-y